An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids

NCT02627989 · clinicaltrials.gov ↗

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: Diflucortolone valerate (Nerisona)
DRUG: Diflucortolone valerate (Texmeten)

Sponsor

LEO Pharma

Collaborators

[object Object]